EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites

On Wednesday, Intelligent Bio Solutions Inc INBS announced that Quantum Traffic Management, a U.K.-based traffic management provider, has adopted INBS Intelligent Fingerprinting Drug Testing Solution across 10 nationwide sites to increase workplace testing efficiency and safety.

With over 30 years of industry experience, Quantum TM operates across the utilities, highways, rail, local authority, and events sectors.

Previously, Quantum TM relied on saliva and urine testing through external occupational health providers.

However, the delays and inefficiencies associated with these methods prompted the company to explore a quicker and more hygienic alternative.

Also Read: SoFi Q4 Earnings: Lackluster FY25 Profit Outlook Overshadows Performance, Stock Slides

INBS' fingerprint sweat-based system enables Quantum TM to conduct on-the-spot drug screening in-house, facilitating rapid decision-making and improved operational efficiency.

Quantum TM Managing Director Scott Powell said the Intelligent Fingerprinting Drug Testing Solution provides greater control over drug testing, which it could manage in-house and increase its testing productivity.

INBS Intelligent Fingerprinting Drug Screening System enables organizations to conduct accurate drug screening tests without requiring specialized staff or facilities, the company said in the press release. Its ability to provide rapid on-site results eliminates many challenges associated with traditional testing methods.

With the company's recent FDA 510(k) submission in December 2024 and plans to enter the U.S. market in early 2025, INBS has the potential to leverage the rapidly expanding global POC drug screening market.

Price Action: INBS stock closed higher by 2.13% to $1.44 Tuesday.

Read Next:

• EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe's $3.6 Billion Drug Screening Market